Research output: Contribution to journal › Article › peer-review
Oxidative Coupling of Guanidines and Isocyanides Under Nickel(II) Catalysis: An Access to Imidazoline Derivatives with Antibacterial Activity. / Гаврилов, Георгий Александрович; Нгуен, Туан Киет; Каткова, Светлана Александровна; Ростовский, Николай Витальевич; Рогачёва, Елизавета; Краева, Людмила Александровна; Кинжалов, Михаил Андреевич.
In: ChemMedChem, 02.02.2025.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Oxidative Coupling of Guanidines and Isocyanides Under Nickel(II) Catalysis: An Access to Imidazoline Derivatives with Antibacterial Activity
AU - Гаврилов, Георгий Александрович
AU - Нгуен, Туан Киет
AU - Каткова, Светлана Александровна
AU - Ростовский, Николай Витальевич
AU - Рогачёва, Елизавета
AU - Краева, Людмила Александровна
AU - Кинжалов, Михаил Андреевич
PY - 2025/2/2
Y1 - 2025/2/2
N2 - A novel and concise approach to rare 2,3,5-triamino-imidazole scaffolds via Ni-catalyzed coupling of alkylisocyanides and N,N′-diarylguanidines has been developed. This reaction features include mild conditions (thermal or visible light activation), a wide substrate scope, and high efficiency. The coupling proceeds through a NiII/NiIV catalytic cycle, involving two-electron aerobic oxidation and the sequential insertion of two isocyanide units into Ni−N bonds.Testing these compounds against pathogens of the ESKAPE panel showed their high activity with a minimum inhibitory concentration down to 0.38 μg/mL.
AB - A novel and concise approach to rare 2,3,5-triamino-imidazole scaffolds via Ni-catalyzed coupling of alkylisocyanides and N,N′-diarylguanidines has been developed. This reaction features include mild conditions (thermal or visible light activation), a wide substrate scope, and high efficiency. The coupling proceeds through a NiII/NiIV catalytic cycle, involving two-electron aerobic oxidation and the sequential insertion of two isocyanide units into Ni−N bonds.Testing these compounds against pathogens of the ESKAPE panel showed their high activity with a minimum inhibitory concentration down to 0.38 μg/mL.
KW - antibacterial activity
KW - imidazole
KW - isocyanide• nickel catalysis
UR - https://www.mendeley.com/catalogue/ce9aae03-43e4-3e47-8ce8-48c767a40cfd/
U2 - 10.1002/cmdc.202400904
DO - 10.1002/cmdc.202400904
M3 - Article
JO - Farmaco
JF - Farmaco
SN - 1860-7179
M1 - e202400904
ER -
ID: 132424795